239 related articles for article (PubMed ID: 17697536)
1. Enzyme replacement therapy in patients with Fabry's disease.
Tsuboi K
J Int Med Res; 2007; 35(4):574-81. PubMed ID: 17697536
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R; Cagnoli L
J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.
Eng CM; Guffon N; Wilcox WR; Germain DP; Lee P; Waldek S; Caplan L; Linthorst GE; Desnick RJ;
N Engl J Med; 2001 Jul; 345(1):9-16. PubMed ID: 11439963
[TBL] [Abstract][Full Text] [Related]
4. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].
Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A
G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795
[TBL] [Abstract][Full Text] [Related]
5. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
[TBL] [Abstract][Full Text] [Related]
6. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
7. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
[TBL] [Abstract][Full Text] [Related]
9. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
[TBL] [Abstract][Full Text] [Related]
10. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
[TBL] [Abstract][Full Text] [Related]
11. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
12. [Enzyme replacement therapy in Fabry's disease].
Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease].
Besson G; Vadot W; Guellerin J
Rev Med Interne; 2010 Dec; 31 Suppl 2():S257-9. PubMed ID: 21211675
[TBL] [Abstract][Full Text] [Related]
14. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
[TBL] [Abstract][Full Text] [Related]
15. [Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease].
Thomaidis T; Relle M; Reinke J; Beck M; Schwarting A
Med Klin (Munich); 2009 Sep; 104(9):699-703. PubMed ID: 19779674
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous enzyme substitution therapy in children with Fabry's disease].
Tøndel C; Laegreid LM; Hirth A; Houge G; Månsson JE; Søvik O
Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3388-90. PubMed ID: 14713976
[TBL] [Abstract][Full Text] [Related]
17. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
Mahmud HM
J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
[TBL] [Abstract][Full Text] [Related]
18. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.
Lui CY; Ju H
Am J Cardiol; 2006 Dec; 98(11):1557-8. PubMed ID: 17126672
[No Abstract] [Full Text] [Related]
19. [Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies].
Pisani A; Visciano B; Capuano I; Mancini A; Riccio E
G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832445
[TBL] [Abstract][Full Text] [Related]
20. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B
G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
